CervoMed Inc. (United States) is listed on the Nasdaq and has a market capitalization of $26.94 million, with shareholders equity totaling $22.96 million.
The Company is listed on the [MARKET_NAME]
Over the past 12 months, CervoMed Inc. reported $645.14 Thousand in revenue, generating net income of $-29.99 million.
Key financial metrics include a P/E ratio of -0.90, a price-to-book (P/B) ratio of 1.17, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker CRVO.